Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia

Código QR

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia

Jirí Masopust,1,2 Ctirad Andrýs,3 Jan Bažant,1 Oldrich Vy&scaron;ata,4 Kamil Kuca,5 Martin Vali&scaron;4 1Department of Psychiatry, Faculty of Medicine in Hradec Kralové, Charles University in Prague, University Hospital Hradec Králové...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a96b3b64f3a242ba89940aa0d4ee656a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk M, et al.
Publicado: (2019)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
por: Washida K, et al.
Publicado: (2013)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam UU, et al.
Publicado: (2014)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu C, et al.
Publicado: (2020)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Kazu Nakazawa, et al.
Publicado: (2017)

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia
por: Liu Y, et al.
Publicado: (2021)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto N, et al.
Publicado: (2012)

The role of family therapy in the management of schizophrenia: challenges and solutions
por: Caqueo-Urízar A, et al.
Publicado: (2015)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016)

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study
por: Wu F, et al.
Publicado: (2018)

Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study
por: Nishimura J, et al.
Publicado: (2014)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
por: Urban-Kowalczyk M, et al.
Publicado: (2015)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Gro&scaron;ić V, et al.
Publicado: (2014)

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia
por: She S, et al.
Publicado: (2019)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review
por: Guo YH, et al.
Publicado: (2014)

Drug and alcohol misuse in first episode psychosis: An observational study
por: Kathleen Crebbin, et al.
Publicado: (2008)

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
por: Gutiérrez-Fernández J, et al.
Publicado: (2015)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

Alzheimer's disease and its treatment costs: case study in the Czech Republic
por: Mohelska H, et al.
Publicado: (2015)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
por: Masopust J, et al.
Publicado: (2018)

Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis
por: Fowler JC, et al.
Publicado: (2021)

Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study
por: Wang Y, et al.
Publicado: (2021)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Ann E Maloney, et al.
Publicado: (2010)

Gastrodin Attenuates Tourette Syndrome by Regulating EAATs and NMDA Receptors in the Striatum of Rats
por: Sun X, et al.
Publicado: (2021)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors
por: Rafael Rivas-Santisteban, et al.
Publicado: (2021)

Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
por: Klimova B, et al.
Publicado: (2018)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Ryan Sai-Ting Chu, et al.
Publicado: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
por: Fujiki R, et al.
Publicado: (2014)

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression
por: Sozeri-Varma G, et al.
Publicado: (2013)

The role of NMDAR antibody in the etiopathogenesis of schizophrenia
por: Timucin D, et al.
Publicado: (2016)

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)